Cedara introduces 3D plug-ins

Article

Canadian software developer Cedara has released a suite of 3D software plug-in components for examining CT and MR images. The products, collectively called Cedara Vivace, allow equipment manufacturers wanting to offer advanced 3D visualization to easily

Canadian software developer Cedara has released a suite of 3D software plug-in components for examining CT and MR images. The products, collectively called Cedara Vivace, allow equipment manufacturers wanting to offer advanced 3D visualization to easily plug the new software into imaging workstations already installed in the field or into new medical imaging devices. In market previews, companies reported being able to plug Vivace into their products in less than a week. Cedara Vivace adapts to the look and feel of its host application. Once plugged in, the 3D software becomes an integral part of the workstation. The suite offers four distinct rendering modes: maximum intensity projection, minimum intensity projection, shaded volume, and unshaded volume, as well as multiplanar reformatting.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.